Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.590
-0.030 (-1.15%)
Oct 6, 2026, 11:59 AM EDT - Market open

Entera Bio Revenue

In the year 2025, Entera Bio had annual revenue of $42.00K, down -76.80%.

Revenue (ttm)
$42.00K
Revenue Growth
-76.80%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
22
Market Cap
448.44M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202542.00K-139.00K-76.80%
Dec 31, 2024181.00K--
Dec 31, 2023---
Dec 31, 2022134.00K-437.00K-76.53%
Dec 31, 2021571.00K206.00K56.44%
Dec 31, 2020365.00K129.00K54.66%
Dec 31, 2019236.00K-264.00K-52.80%
Dec 31, 2018500.00K--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Arvinas316.70M
Puma Biotechnology231.24M
REGENXBIO174.48M
Autolus Therapeutics117.39M
Capricor Therapeutics11.13M
Allogene Therapeutics4.64M
Neurogene925.00K
ProKidney818.00K
Revenue Rankings